SOLUTION PREPARATION CONTAINING STABILIZED ANTIBODY
www.patentreply.ai/tools/patent-expiration/US11612562Important: This calculator does not include patent term extension under 35 U.S.C. § 156, which may apply to certain drug, biologic, animal drug, and medical device patents.
Learn how PTE is calculatedSolution Preparation Containing Stabilized Antibody
Application No. 16008486
January 20, 2031
4y 140d remainingEarliest effective filing
Jan 20, 2011
+ 20 years
Jan 20, 2031
PTA +0d
Jan 20, 2031
TD applied
Jan 20, 2031
Final
Jan 20, 2031
Filing Date
June 14, 2018
Earliest Effective Filing
January 20, 2011
Issue Date
March 28, 2023
PTA
0 days
Base Expiry (before PTA)
January 20, 2031
Could not resolve calculation details
Multispecific Antigen-binding Molecules Having Blood Coagulation Factor Viii (fviii) Cofactor Function-substituting Activity And Pharmaceutical Formulations Containing Such A Molecule As An Active Ingredient
Filing Date
Nov 6, 2018
Earliest Effective Filing
Sep 27, 2018
Issue Date
Sep 1, 2020
PTA
0 days
Calculated Expiration
Sep 27, 2038
Bispecific Antibodies
Filing Date
Aug 30, 2013
Earliest Effective Filing
Nov 17, 2011
Issue Date
May 10, 2016
PTA
+376 days
Calculated Expiration
Nov 27, 2032
Solution Preparation Containing Stabilized Antibody
Filing Date
Jun 14, 2018
Earliest Effective Filing
Jan 20, 2011
Issue Date
Mar 28, 2023
PTA
0 days
Calculated Expiration
Jan 20, 2031
Antibody-containing Preparation
Filing Date
Oct 12, 2018
Earliest Effective Filing
Apr 27, 2017
Issue Date
Nov 4, 2025
PTA
+342 days
Calculated Expiration
Apr 4, 2038
Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.